KDR and neoplasm: To examine the activation status of FGFR2 and the levels of FGF2 and FGFR2 in Mock and VEGFR2-Fc–expressing tumors, we conducted Western blot analysis of tumor lysates from tumors resected at a volume of ~500 mm3.